We are dedicated to the development of medical technologies that enable the design of new and personalized treatments and the rapid translation of these treatments to the patient.
Our focus? On cancer and cardiovascular diseases and, to a lesser extent, neurodegenerative and infectious / autoimmune diseases.
CTMM is a public-private consortium that comprises a multidisciplinary group of parties – universities, academic medical centers, medical technology enterprises and chemical and pharmaceutical companies.
CTMM headquarters are located at the High Tech Campus in Eindhoven, The Netherlands.